Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
16R-BH4[1] Sapropterin[1] D08505 --[3] 86, 124, 240
2Antiplatelets----[1] 124
3ARICEPT[1] Donepezil[2] D00670 ,
D07869 		[1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[4] 6, 13, 78, 124
4ARICEPT 5*28 CPR 5 MG[1] Donepezil[2] D00670 ,
D07869 		[1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[1] 124
5BH4----[5] 51, 86, 124, 240, 299
6CILOSTAZOL[1] Cilostazol[1] D01896 [3] PDE3A,
PDE3B,
TBXA2R 💬		[14] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 51, 70, 124
7Dabigatran[1] Dabigatran[1] D09707 [1] F2 💬[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[4] 51, 85, 91, 124
8Donepezil[1] Donepezil[2] D00670 ,
D07869 		[1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[9] 5, 6, 13, 46, 78, 124, 127, 156, 206
9Donepezil hydrochloride[1] Donepezil[2] D00670 ,
D07869 		[1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[3] 6, 124, 156
10E2020----[1] 124
11Fremanezumab[1] Fremanezumab[1] D11055 [1] CALCA 💬[2] Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬[2] 124, 226
12HOV-12020 (Palm tocotrienols complex)----[1] 124
13Phenoptin----[2] 124, 240
14Sapropterin[1] Sapropterin[1] D08505 --[3] 86, 124, 240